AI assistant
Marinomed Biotech AG — Director's Dealing 2019
Feb 22, 2019
749_dirs_2019-02-22_5a35ca58-5d50-4825-bea4-92b3ff844f24.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Publication Date: 22.02.2019 12:44 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)
Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
personal data: responsible party: name: Simon Nebel (natural person) ------------------------------------------------------------------------------- reason: reason: responsible party is a person with managerial responsibilities function: Chairman of the supervisory board ------------------------------------------------------------------------------- issuer information: name: Marinomed Biotech AG Legal Entity Identifier (LEI): 529900GN3B1EN80XF405 ------------------------------------------------------------------------------- information about deal: ISIN: ATMARINOMED6 description of the financial instrument: Stock type: conversion ISIN AT000A1WD52 date: 20.02.2019; UTC+01:00 market: WIENER BOERSE AG, XWBO currency: Euro price volume 40,87 489 total volume: 489 total price: 19985,43 average price: 40,87 -------------------------------------------------------------------------------- end of announcement euro adhoc
| issuer: | Marinomed Biotech AG |
|---|---|
| Veterinärplatz 1 | |
| A-1210 Wien | |
| phone: | 0043250774460 |
| FAX: | 0043250774493 |
| mail: | [email protected] |
| WWW: | www.marinomed.com |
| ISIN: | ATMARINOMED6, AT0000A1WD52 |
| indexes: | |
| stockmarkets: Wien | |
| language: | English |
| Aussendung übermittelt durch euro adhoc | |
|---|---|
| The European Investor Relations Service |